IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia

E-ISSN： 2212-3873|15|3|242-250

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.3, 2015-01, pp. : 242-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-22 and Its Receptors, New Players in the Inflammatory Network

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 3, 2006-08 ,pp. : 251-257

Bentham Science Publishers

Access to resources Recommend Favorite

Augmenting T Helper Cell Immunity in Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 4, 2005-12 ,pp. : 365-371

Bentham Science Publishers

Access to resources Recommend Favorite

IL-22 inhibitors to treat inflammatory disorders such as arthritis

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 373-375

Informa Healthcare

Access to resources Recommend Favorite

New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease

By Pandya Devanshi Rahman Saifur Wigdahl Brian Khan Zafar K Jain Pooja

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 481-493

Future Medicine

Access to resources Recommend Favorite

The cytokines (IFN-γ, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-β1) levels in adults with immune thrombocytopenia

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 9, 2014-09 ,pp. : 694-697

Govi-Verlag

Access to resources Recommend Favorite